The state’s effort to expand the “right to try” is making headway, and the first drugs are about to be reviewed.

The company says it has found a new window into how its models arrive at answers. We spoke with senior editor Will Douglas Heaven about it. This story originally appeared in The Algorithm, our weekly ...

Kris DeVault’s toddler has a rare genetic disease. He’s desperate to try an experimental drug, even though it has not been ...

In June 2024, a small company called Zanskar purchased a geothermal power plant in New Mexico that was failing fast. The ...

Once its treatment is rubber-stamped, the company can sell it via experimental treatment clinics, the first of which is ...

It makes it easy to trick them into doing things they shouldn’t, such as telling you how to sabotage an aircraft’s navigation ...

Why sovereignty over data and models is becoming a defining factor in enterprise AI success,as well as a prerequisite for forging safe agentic systems. In partnership withEnterpriseDB When generative ...

A global survey finds cloud investment becoming a mainstay for technology development and operational efficiency In partnership withInfosys Cobalt The cloud, fundamentally a tool for cost and resource ...

As the AI boom heats up, the semiconductor titans are waging a fierce talent war with flashy bonuses, aggressive recruiting, ...

The company says it has cracked the code for error correction and is building a modular machine in New York state. IBM announced detailed plans today to build an ...

His colleagues are doing the same. They feel demoralized by the $476,000 bonus that SK Hynix is set to pay its employees, ...

A decade-old experiment showed OpenAI how far an AI will go to achieve the goals it’s given.  This story originally appeared ...